Viewing nowDonghwa Memantine Tablet 20mg (Memantine Hydrochloride)
Memantine Hydrochloride 20mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

MFDS item code 202500125 · Approved 2025.01.16 · Insurance code 642707740
Treatment of moderate to severe Alzheimer's disease
This medication is used to treat symptoms of Alzheimer's disease ranging from moderate to severe. It helps alleviate cognitive decline and memory loss in patients, aiding in the maintenance of quality of life. Additionally, it improves behavioral and psychological symptoms, reducing the burden on both patients and caregivers. Overall, it is effective in slowing the progression of Alzheimer's disease and improving symptoms.
Treatment should be initiated only by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only when a caregiver is available to regularly check that the patient is taking the medicine. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed regularly. This medicine is administered orally once daily, at the same time each day. If necessary, this medicine may be administered twice daily. It may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1-7): Administer 5mg once daily for 7 days. Week 2 (Days 8-14): Administer 10mg once daily for 7 days. Week 3 (Days 15-21): Administer 15mg once daily for 7 days. From Week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose-escalation method, at least 7 days after starting treatment. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This medication should not be used in patients with allergies to its components, severe liver dysfunction, or significantly impaired kidney function. It should be administered with caution in patients with epilepsy or those who have a history of seizures, as well as in individuals predisposed to seizures. Additionally, patients taking drugs acting on NMDA receptors such as amantadine, ketamine, or dextromethorphan are at increased risk of side effects, and this medication should not be used together with them. Patients with dietary habits or specific conditions that can increase urinary acidity (pH) should be closely monitored during treatment. Recent cases of myocardial infarction, congestive heart failure, and uncontrolled hypertension require caution, as the safety of this medication has not been fully established in these patient populations. During treatment with this medication, side effects such as dizziness, headaches, constipation, drowsiness, hypertension may occur, and in severe Alzheimer's patients, hallucinations or psychotic symptoms can occasionally appear. This medication can interact with other drugs, so it is important to consult with a physician or pharmacist, especially if taking NMDA antagonists, antipsychotic medications, skeletal muscle relaxants, or anticoagulants. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this medication, and breastfeeding women are advised to discontinue breastfeeding as this medication may be excreted in breast milk. The safety and efficacy of this medication in children or adolescents under 18 years have not been established. In cases of overdose, severe symptoms in the central nervous system and gastrointestinal tract may occur, so strict adherence to the prescribed dosage is necessary, and immediate medical attention should be sought in case of overdose. Finally, this medication may decrease patient responsiveness, increasing the risk of accidents while driving or operating machinery, so caution is required. Lastly, this medication should be stored out of reach of children, and transferring it to another container is not recommended as it aids in maintaining the quality of the medication.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature. This helps maintain the medication's effectiveness for a longer period.
Pink oval film-coated tablet
30 tablets/box [10 tablets/PTP × 3], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 20mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.